CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 72 filers reported holding CULLINAN ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,508,000 | -72.0% | 429,646 | -72.0% | 0.10% | -67.4% |
| Q2 2022 | $19,686,000 | +22.4% | 1,535,560 | 0.0% | 0.29% | +68.2% |
| Q1 2022 | $16,077,000 | -28.6% | 1,535,560 | 0.0% | 0.17% | -22.1% |
| Q4 2021 | $22,509,000 | -44.1% | 1,535,560 | -16.3% | 0.22% | -40.0% |
| Q3 2021 | $40,237,000 | -13.1% | 1,835,560 | 0.0% | 0.37% | -1.3% |
| Q2 2021 | $46,277,000 | -35.5% | 1,835,560 | 0.0% | 0.38% | -34.3% |
| Q1 2021 | $71,699,000 | – | 1,835,560 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |